ANI PHARMACEUTICALS, INC Current Liabilities
ANI PHARMACEUTICALS, INC (ANIP) had Current Liabilities of $283.65 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $283.65M.
- 2026-03-31: Liabilities, Current $239.51M.
- 2025-12-31: Liabilities, Current $278.11M.
- 2025-09-30: Liabilities, Current $270.56M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $283.65M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $239.51M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $278.11M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $270.56M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $236.84M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $201.81M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $194.45M 10-K · filed 2026-02-27 | $193.68M 10-K · filed 2025-02-28 |
| 2024-09-30 | $189.93M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $139.98M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $136.89M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $145.48M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $134.35M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $122.86M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $125.83M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $99.44M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $81.63M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $96.31M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $79.53M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $87.54M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $84.87M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $89.45M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $82.77M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $78.56M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $75.90M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $79.09M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $79.36M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $61.68M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $170.71M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $166.79M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $165.07M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $165.55M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $46.90M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $39.68M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $39.65M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $39.23M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $36.38M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $28.29M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $32.42M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $31.95M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $30.49M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $24.73M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $16.21M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $11.76M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $12.19M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $6.95M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $9.07M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $13.23M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $8.14M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $3.83M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $4.56M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.54M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $6.60M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $6.16M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $7.71M 10-K · filed 2014-02-28 | $10.59M 10-K · filed 2013-02-28 |
| 2012-09-30 | $10.92M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $16.37M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $6.08M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $7.23M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $11.50M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $11.48M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $8.18M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |